Prime is a fully integrated Pharmaceutical Company with an established presence across the globe. We are involved in the CMO & CDMO business of pharmaceutical preparations in various dosage forms catering to diverse Therapeutic categories. Prime has an advanced State of the Art - Research and Development Centre with proven scientific competence to develop formulations as Patent Non-infringing and Niche generics in differentiated dosage form for global regulated markets.

The company is engaged with MNC's like GSK, Sanofi, Novartis, Sandoz, J&J, Abbott, Viatris and many other Customers across 60 plus countries in key markets of India, Japan, Australia & New Zealand, United Kingdom, Rest of Europe, Canada, Far East Asia, GCC, Africa, LATAM and CIS for formulations R&D and manufacturing in various dosage forms.

With close to 4000 employees worldwide, Prime is providing a strong platform to it’s employees to learn, contribute and grow and is committed to providing quality medicines to patients world over to make their lives healthier.

In the year 2015, Prime achieved the transformational milestone in it’s over 40 years of existence and became part of Meiji Group a leading Japanese conglomerate listed on Tokyo stock exchange and having business interests across the globe in Pharmaceuticals, food and nutrition products.